Genetic interaction of GSH metabolic pathway genes in cystic fibrosis
Open Access
- 10 June 2013
- journal article
- research article
- Published by Springer Nature in BMC Medical Genetics
- Vol. 14 (1) , 60
Abstract
Cystic fibrosis (CF) is a monogenic disease caused by CFTR gene mutations, with clinical expression similar to complex disease, influenced by genetic and environmental factors. Among the possible modifier genes, those associated to metabolic pathways of glutathione (GSH) have been considered as potential modulators of CF clinical severity. In this way it is of pivotal importance investigate gene polymorphisms at Glutamate-Cysteine Ligase, Catalytic Subunit (GCLC), Glutathione S-transferase Mu 1 (GSTM1), Glutathione S-transferase Theta 1 (GSTT1), and Glutathione S-transferase P1 (GSTP1), which have been associated to the GSH metabolic pathway and CF clinical severity. A total of 180 CF’s patients were included in this study, which investigated polymorphisms in GCLC and GST genes (GCLC -129C>T and -3506A>G; GSTM1 and GSTT1 genes deletion, and GSTP1*+313A>G) by PCR and PCR-RFLP associating to clinical variables of CF severity, including variables of sex, clinical scores [Shwachman-Kulczycki, Kanga e Bhalla (BS)], body mass index, patient age, age for diagnosis, first clinical symptoms, first colonization by Pseudomonas aeruginosa, sputum’s microorganisms, hemoglobin oxygen saturation in the blood, spirometry and comorbidities. The CFTR genotype was investigated in all patients, and the genetic interaction was performed using MDR2.0 and MDRPT0.4.7 software. The analysis of multiple genes in metabolic pathways in diseases with variable clinical expression, as CF disease, enables understanding of phenotypic diversity. Our data show evidence of interaction between the GSTM1 and GSTT1 genes deletion, and GSTP1*+313A>G polymorphism with CFTR gene mutation classes, and BS (Balance testing accuracy= 0.6824, p= 0.008), which measures the commitment of bronchopulmonary segments by tomography. Polymorphisms in genes associated with metabolism of GSH act on the CF’s severity.Keywords
This publication has 32 references indexed in Scilit:
- The ACE gene D/I polymorphism as a modulator of severity of cystic fibrosisBMC Pulmonary Medicine, 2012
- Genetic Variation and Clinical Heterogeneity in Cystic FibrosisAnnual Review of Pathology: Mechanisms of Disease, 2012
- Power of Data Mining Methods to Detect Genetic Associations and InteractionsHuman Heredity, 2011
- Genes that determine immunology and inflammation modify the basic defect of impaired ion conductance in cystic fibrosis epitheliaJournal of Medical Genetics, 2010
- Glutathione S-transferases related to P. aeruginosa lung infection in cystic fibrosis children: Preliminary studyClinical Biochemistry, 2009
- Genetic analysis of CC16, OGG1 and GCLC polymorphisms and susceptibility to COPDRespirology, 2006
- Variants in the Glutamate-Cysteine-Ligase Gene Are Associated with Cystic Fibrosis Lung DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Modifier genes in cystic fibrosisPediatric Pulmonology, 2005
- Power of multifactor dimensionality reduction for detecting gene‐gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneityGenetic Epidemiology, 2003
- Liver disease in pediatric patients with cystic fibrosis is associated with glutathione S-transferase P1 polymorphismHepatology, 2002